VANCOUVER, BRITISH COLUMBIA–(Marketwired – April 6, 2017) – ICC International Cannabis Corporation (TSX VENTURE:ICC) (“ICC” or the “Company“) is pleased to announce that it has been included in the Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ). The Company represented approximately 2.1% of the index weight as at market close on April 5, 2017.
“The establishment of the first medical marijuana ETF is an important milestone for the cannabis industry as a whole and specifically for ICC. In a fast changing industry, we believe this ETF is a significant vote of confidence for this up and coming asset class,” commented Guillermo Delmonte, Chief Executive Officer of the Company. “As a producer of cannabis with operations outside of Canada, being included in the ETF serves as another layer of credibility for the Company.”
To be eligible for inclusion in this ETF, issuers must meet certain minimum asset, market capitalization and liquidity thresholds.
ABOUT ICC INTERNATIONAL CANNABIS CORPORATION
The Company has operations in Uruguay, and is focused on the licensed production, development and sale of recreational cannabis, cannabinoid extracts and by-products for medicinal uses and industrial hemp. For more information, please see www.intcannabiscorp.com.
Neither the TSX Venture Exchange (“TSXV”) nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict, including the Company’s ability to obtain any requisite regulatory approvals. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company’s filings with Canadian securities regulators, which filings are available at www.sedar.com.
Guillermo Delmonte
Chief Executive Officer and Director
598-2900-0000
ir@intcannabiscorp.com
www.intcannabiscorp.com